Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liproca Depot in Localized Prostate Cancer (Active Surveillance)
NCT03348527Phase 2Completed
- Sponsor
- LIDDS AB
- Start
- May 2017
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of 2-hydroxyflutamide depot in prostate cancer (PCa), sponsored by LIDDS AB. Started May 2017; status: completed.
02
Drugs
2-hydroxyflutamide depot
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03348527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03348527.